Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1471 of 6351
-
Gentler chemo combo shows promise for older leukemia patients
Disease control OngoingThis is a single arm open-label phase 2 trial to study the safety and efficacy of SC Blinatumomab in combination with low-intensity chemotherapy for older or unfit patients with B-ALL.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Blood pressure drug may curb aggression in autism
Disease control Recruiting nowThe goal of this clinical trial is to learn if propranolol can help reduce challenging behaviors associated with Autism Spectrum Disorder, including aggression, self-injury, and severe disruptive behaviors. Participants will be randomly assigned to receive either propranolol or a…
Phase 2 • Sponsor: Jeremy Veenstra-vanderweele • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Pfizer launches early trial of PF-08634404 combo for tough lung cancers
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be r…
Phase 1/2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Ecstasy could ease severe nerve pain in new pilot trial
Symptom relief Recruiting nowThis is a Health Canada regulated internal pilot study designed to assess the feasibility, tolerability, and preliminary efficacy of 3, 4-methylenedioxymethamphetamine hydrochloride capsules-AT for chronic neuropathic pain to inform a larger, fully powered multi-center study. Thi…
Phase 2 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New hope for rare vasculitis: obinutuzumab steps in where rituximab fails
Disease control Recruiting nowCryoglobulinemic vasculitis (CV) is a rare life threatening systemic immune-complex-mediated vasculitic syndrome. Symptoms range from arthralgia, purpura to more severe manifestations such as peripheral neuropathy, glomerulonephritis, and skin necrosis.1 CV is associated with sig…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Heart pouch showdown: which device best prevents strokes?
Disease control Not yet recruitingClinical investigation with CE-marked medical devices, multicenter, prospective, randomized and controlled. Patients with non-valvular atrial fibrillation at high embolic risk and with at least one high bleeding risk criterion according to the Munich consensus document will be ra…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo attack for tough leukemia: CAR-T cells then transplant
Disease control Not yet recruitingThis study aims to evaluate whether an innovative combination therapy (CLL1 CAR-T sequential allogeneic hematopoietic stem cell transplantation) is safe, feasible and effective for the treatment of relapsed/refractory acute myeloid leukemia (R/R AML).
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for kids with rare calcium disease: encaleret trial launches
Disease control Recruiting nowThe overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.
Phase 2/3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could an arthritis drug ease Parkinson's symptoms?
Disease control Recruiting nowNeuroinflammation is considered one of the most important factors contributing critically to pathophysiology of PD . Recently, high mobility group box-1 (HMGB1) protein has been encoded as a potential inflammatory biomarker in PD. HMGB1 mediates immune response mostly through end…
Phase 2 • Sponsor: Ihab Elsayed Hassan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New gel could ease pain and heal wounds for kids with butterfly skin
Symptom relief Recruiting nowThis is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, a pair of matching index w…
Phase 2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple steroid prevent strokes after brain aneurysm stenting?
Disease control Not yet recruitingStudy Title: Testing Methylprednisolone to Prevent Strokes After a Stent Procedure for Brain Aneurysms What is the purpose of this study? This study aims to find out if a short course of a steroid medicine called methylprednisolone can help prevent strokes and other brain-relate…
Phase 4 • Sponsor: Duan Chuanzhi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New combo tackles breast cancer in the liver
Disease control Recruiting nowThis phase II trial tests how well cemiplimab and transarterial radioembolization (TARE) with yttrium-90 (Y90) SIR-Spheres, registered trademark, works in treating breast cancer that has spread from where it first started (primary site) to the liver (metastatic). Immunotherapy wi…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could keeping patients breathing naturally during lung transplant speed recovery?
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm clinical study is to learn whether a breathing-preserved anesthesia-surgical strategy can improve early recovery and perioperative survival in adults undergoing rescue/bridge lung transplantation. The main questions it aims t…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New lung transplant method lets patients breathe naturally during surgery
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm cohort study is to learn whether a lung transplantation approach that preserves patients' spontaneous breathing during surgery can improve early recovery in adults aged 70 years and older undergoing allogeneic lung transplanta…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental cell therapy takes on deadliest brain cancer
Disease control Not yet recruitingThis is an open-Label, dose-escalation, multiple administration, exploratory clinical study to evaluate the safety, tolerability, and anti-tumor activity of TH-CART-027 cell injection in subjects with recurrent or progressive grade 4 glioma
Early phase 1 • Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
AI predicts which cancer patients will develop liver spread
Diagnosis Recruiting nowThis is a prospective, multicenter, observational study designed to validate the predictive accuracy of a pre-developed multimodal deep learning model. The model integrates preoperative contrast-enhanced CT scans, digitized postoperative pathology images, and standard clinical da…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Recruiting nowThis study will investigate the safety and effectiveness of a new combination treatment for patients with advanced bile duct cancer. The treatment combines standard chemotherapy drugs (gemcitabine and cisplatin) with two additional medications: adebrelimab and simvastatin. All p…
Phase 1/2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Keto diet may supercharge cancer immunotherapy, early trial hints
Disease control Recruiting nowThis study investigates whether raising blood levels of beta-hydroxybutyrate (BHB) - a natural molecule produced by the body during fasting or a low-carbohydrate diet - is safe and feasible and can improve the effectiveness of immunotherapy in patients with multiple myeloma, whil…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Liver clues: a new way to stage heart amyloidosis?
Knowledge-focused Recruiting nowTransthyretin cardiac amyloidosis (ATTR-CA) is a progressive infiltrative cardiomyopathy caused by the deposition of misfolded transthyretin protein within the myocardium. Current disease staging and follow-up strategies mainly rely on cardiac biomarkers and renal function; howev…
Sponsor: University of Messina • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can emotional patterns reveal the true nature of teen trauma?
Knowledge-focused Recruiting nowThis study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD). As emotional dysreg…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC